Clinical Trials Logo

Hyperlactatemia clinical trials

View clinical trials related to Hyperlactatemia.

Filter by:

NCT ID: NCT03649009 Recruiting - Hyperlactatemia Clinical Trials

Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The study aimed to assess the effectiveness of intravenous thiamine as compared with placebo in reducing the lactate level in septic shock patients.

NCT ID: NCT03115970 Not yet recruiting - Trauma, Multiple Clinical Trials

Feasibility of Lactate Level Evaluation in Prehospital Care in Trauma

Start date: May 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Capillary or venous lactate level evaluation in prehospital care could be simple and beneficial tool for optimising prehospital care in patients with severe trauma.

NCT ID: NCT03078712 Completed - Septic Shock Clinical Trials

Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study

ANDROMEDA
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Septic shock is a highly lethal condition associated with a mortality risk of 30 to 60%. Optimizing tissue perfusion and oxygenation is the aim to decrease mortality and morbidity in septic shock patients. Persistent hyperlactatemia after initial resuscitation is particularly difficult to interpret, although optimizing systemic blood flow might reverse ongoing hypoperfusion. Nevertheless, if persistent hyperlactatemia is caused by non-hypoperfusion-related mechanisms, then sustained efforts aimed at increasing cardiac output (CO) could lead to detrimental effects of excessive fluids or inotropes. Another potential alternative resuscitation target is peripheral perfusion as assessed by capillary refill time (CRT), mottling score or central-to-toe temperature differences. Reversal of abnormal peripheral perfusion might represent improvement in tissue hypoperfusion with the advantage of a faster recovery than lactate. Hypothesis: Peripheral perfusion guided resuscitation in septic shock is associated with lower mortality, less organ dysfunctions, less mechanical ventilation (MV), less vasopressor load, and less renal replacement therapies than a lactate-targeted resuscitation strategy. Main Objective To test if peripheral perfusion targeted resuscitation in septic shock is associated with lower 28-day mortality than a lactate targeted resuscitation. Design: Multicenter, Parallel Assignment randomized controlled study, conducted under supervision of an independent Data Safety Monitoring Board (DSMB). Interventions: 1. Active Comparator- Peripheral Perfusion guided resuscitation 2. Active Comparator- Lactate guided resuscitation Randomization: 1:1 the randomization using a block size of eight will be stratified according to participating centers. Trial size: 400 randomized patients in 30 ICUs.

NCT ID: NCT03062683 Recruiting - Syncope Clinical Trials

Serum Lactate in Convulsive Syncopes Compared to Non-convulsive Syncopes

Start date: January 1, 2017
Phase: N/A
Study type: Observational

The investigators compared the serum lactate, serum prolactin and serum creatine kinase concentrations following convulsive and non-convulsive syncopes. The aim of the study was to investigate their importance as diagnostic markers in transient loss of consciousness.

NCT ID: NCT03025659 Completed - Clinical trials for Post-cardiac Surgery

Lactate Acidosis in Postoperative Hearts

Start date: May 28, 2017
Phase:
Study type: Observational

This is a single-center, observational study. Investigators aim to characterize the metabolism of lactate in children over the first forty-eight hours following cardiac surgery. Blood samples will be obtained up to 12 timepoints. Samples will be analyzed for concentration of pyruvate. Results will be compared to standard of care laboratory results for lactate and other direct and indirect measures of cardiac output.

NCT ID: NCT02950753 Completed - Hyperlactatemia Clinical Trials

Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?

Start date: January 4, 2017
Phase: Early Phase 1
Study type: Interventional

Lactated Ringer's (LR) solution bolus is commonly administered in the emergency department setting to seriously ill patients. It is also common to obtain blood samples to determine serum lactate levels to aid in the assessment of the patient's degree of illness. This study endeavors to determine if serum lactate levels are affected by LR fluid administration in healthy adult individuals as compared to those who receive Normal Saline (NS). Healthy adult volunteers will be used as subjects so that the illness of hospital patients does not confound the results.

NCT ID: NCT00471614 Completed - HIV Infections Clinical Trials

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

Start date: April 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether uridine supplementation will improve insulin sensitivity and overall carbohydrate metabolism in HIV-positive subjects who are currently undergoing treatment with antiretroviral regimens containing stavudine or zidovudine and who have evidence of impaired mitochondrial function and insulin resistance.

NCT ID: NCT00390273 Completed - Hyperlactatemia Clinical Trials

Effect of Metformin on Lactate Metabolism

Start date: December 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of this study is to evaluate the influence of metformin on lactate metabolism. The main outcome is the lactate production following an exogenous lactate overload in healthy male subjects without metformin and one week later with metformin.

NCT ID: NCT00270673 Completed - Hyperlactatemia Clinical Trials

Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)

Start date: February 2006
Phase: Phase 3
Study type: Interventional

Blood lactate levels have long been related to tissue hypoxia, a severe condition in critically ill patients associated with the development of organ system failure and subsequent death. Increased blood lactate levels and failure to normalize blood lactate levels during treatment have been associated with increased morbidity and mortality. However, evidence of improved clinical outcome of lactate-directed therapy is limited and difference in the use of blood lactate monitoring in the intensive care unit exists between hospitals. This warrants a study on the efficacy of early blood lactate-directed therapy. In this study the efficacy of 8 hours of early lactate-directed therapy (therapy aimed at resolving tissue hypoxia that is guided by serial blood lactate levels) will be compared with 8 hours of control group therapy (without lactate measurement).